Telaprevir-Based Triple Therapy for Re-Treatment Chronic HCV Patients With Genotype 1, Including the Null-Response: A Single Center Experience From Turkey
Virology: Research and Reviews
doi 10.15761/vrr.1000109
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Open Access Text Pvt, Ltd.